Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Povidone iodine, hydrogen peroxide and chlorhexidine mouthwashes reduce SARS-CoV2 burden in whole mouth fluid and respiratory droplets

Bagavad Gita Jayaraman, Gunaseelan Rajan, View ORCID ProfilePriya Kannian, Chandra Lavanya, Krittika Ravichandran, Nagalingeswaran Kumarasamy, Kannan Ranganathan, Veeraraghavan Aswini, Pasuvaraj Mahanathi, Stephen Challacombe, Jennifer Webster-Cyriaque, View ORCID ProfileNewell W Johnson
doi: https://doi.org/10.1101/2021.02.25.21252488
Bagavad Gita Jayaraman
1Chennai Dental Research Foundation, Chennai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gita70.geetha{at}gmail.com priyakannian{at}gmail.com
Gunaseelan Rajan
1Chennai Dental Research Foundation, Chennai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Priya Kannian
2VHS Laboratory Services, Department of Clinical Research, VHS Hospital, Chennai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Priya Kannian
  • For correspondence: gita70.geetha{at}gmail.com priyakannian{at}gmail.com
Chandra Lavanya
4Department of Oral Pathology, Ragas Dental College and Hospital, Chennai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Krittika Ravichandran
1Chennai Dental Research Foundation, Chennai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nagalingeswaran Kumarasamy
3VHS-Infectious Diseases Medical Centre, VHS Hospital, Chennai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kannan Ranganathan
4Department of Oral Pathology, Ragas Dental College and Hospital, Chennai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veeraraghavan Aswini
2VHS Laboratory Services, Department of Clinical Research, VHS Hospital, Chennai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pasuvaraj Mahanathi
2VHS Laboratory Services, Department of Clinical Research, VHS Hospital, Chennai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Challacombe
5Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Webster-Cyriaque
6University of North Carolina, Chapel Hill, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Newell W Johnson
1Chennai Dental Research Foundation, Chennai, India
3VHS-Infectious Diseases Medical Centre, VHS Hospital, Chennai, India
5Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, UK
7Menzies Health Institute Queensland, Griffith University, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Newell W Johnson
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

SARS-CoV2 is transmitted primarily through oral mouth secretions and respiratory droplets. Commercial mouthwashes, povidone iodine (PI), hydrogen peroxide (HP) and chlorhexidine (CHX) have been tested in cell culture and RT-PCR studies for their efficacy to reduce SARS-CoV2 burden. Here, we evaluated SARS-CoV2 burden in whole mouth fluid (WMF) and respiratory droplets (RD) samples before and after the use of PI, HP or CHX mouthwashes in hospitalized COVID-19 patients using RT-PCR and rapid antigen test (RAT). Thirty-six SARS-CoV2 RT-PCR-positive in-patients were randomly assigned to one of the four groups: 20 and 60 minutes after 1% w/v PI or 1.5% HP; 90 and 180 minutes after 1.5% HP or 0.2% w/v CHX. WMF and RD samples were collected concurrently at baseline and after the two different time points. RD (92%) showed a higher reduction in SARS-CoV2 burden than WMF samples (50%; p=0.008). SARS-CoV2 burden was statistically lower at both 20 minutes (p=0.02) and 60 minutes (p=0.03) with PI; at 20 minutes with HP (p=0.0001); and 90 minutes with CHX (p=0.04). The overall and individual mean logarithmic reductions in the WMF and RD samples were greater than 1.0 at 20, 60 and 90 minutes after PI, HP or CHX. RAT-positive patients at 90 minutes post-treatment (n=3) demonstrated a one log increase in virus copies. Among the three RAT-negative post-treatment patients, SARS-CoV2 burden declined by one log in two while the third patient had a slight increase in RNA copies. In conclusion, we have shown for the first time that the mouthwashes, PI, HP and CHX can reduce the SARS-CoV2 burden in the concurrently collected RD and WMF samples. RAT is more appropriate than RT-PCR to evaluate the efficacy of the mouthwashes.

Introduction

Whole mouth fluid (WMF) and respiratory droplets (RD) primarily transmit SARS-CoV2. In vitro cell culture and RT-PCR studies in WMF have shown that commercial mouthwashes - chlorhexidine (CHX), povidone iodine (PI) and hydrogen peroxide (HP) have significant virucidal activity against SARS-CoV2.1,2 However, RT-PCR of RNA viruses will detect both live and dead viruses, and should be interpreted cautiously. We have previously used rapid antigen testing (RAT) to detect SARS-CoV2 proteins in WMF thereby depicting its infectious state.4 This study evaluates SARS-CoV2 burden in WMF and RD samples before and after the use of PI, HP or CHX mouthwashes in hospitalized COVID-19 patients using RT-PCR and RAT.

Methods

The study was approved by VHS-Institutional Ethics Committee (VHS-IEC/60-2020). Thirty-six SARS-CoV2 RT-PCR-positive (nasopharyngeal swab [NPS] and WMF) in-patients were randomly assigned after written informed consent to one of the four groups – 20 and 60 minutes after 1% w/v PI or 1.5% HP; 90 and 180 minutes after 1.5% HP or 0.2% w/v CHX. Early morning unstimulated drooled WMF samples and RD exhaled onto Whatman No.1 filter paper discs contained within surgical face masks were collected at baseline and at the two different time points after the corresponding mouthwash. Quantitative SARS-CoV2 RT-PCR was done using the automated QIAAmp Viral RNA kit (QIAGEN, Germany), Lightcycler 96 (Roche, USA) and a validated standard curve. SARS-CoV2 antigen in the WMF was tested in a subset of six patients before and after HP by RAT (SD Biosensor, Korea).4 Analyses (mean and standard deviations [SD]) and statistics (t-test and Fisher exact) were done using Microsoft Excel, VassarStats and Social Science Statistics.

Results

Among the 36 patients, 13 (36%) were RT-PCR positive in RD samples at baseline. A 50% or greater decrease in the SARS-CoV2 copies from the baseline was considered significant. The reduction was significantly higher in RD (92%; 12/13) than WMF samples (50%; 18/36; p=0.008), perhaps due to lower baseline burden in RD samples (Table 1). Compared to the baseline, the mean copy numbers were statistically lower at both 20 minutes (p=0.02) and 60 minutes (p=0.03) with PI; at 20 minutes with HP (p=0.0001); and 90 minutes with CHX (p=0.04). The overall and individual mean logarithmic reductions (MLR) in the WMF and RD samples were greater than 1.0 at 20, 60 and 90 minutes after PI, HP or CHX (Table 1).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1:

Mean logarithmic reduction in SARS-CoV2 copies in the whole mouth fluid (WMF) and respiratory droplet (RD) samples by RT-PCR after the mouthwash

WMF samples from six patients were tested for SARS-CoV2 antigens by RAT at baseline and at either 20 minutes (n=3) or 90 minutes (n=3) after HP. Six baseline samples were RAT-positive. Patients who remained RAT-positive at 90 minutes post-treatment (n=3) demonstrated a one log increase in virus copies (Table 2). Among the three patients who became RAT-negative post-treatment, in two individuals the SARS-CoV2 burden declined by one log. However, in the third patient a slight increase in RNA copies was detected.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2:

Comparison between RAT and RT-PCR for the determination of the reduction of SARS-CoV2 burden in whole mouth fluid samples before and after the use of hydrogen peroxide (HP)

Discussion

WMF and RD are primary modes of SARS-CoV2 transmission. Studies are reporting the efficacy of mouthwashes in reducing SARS-CoV2 burden in WMF. In this study, we report for the first time, reduction of SARS-CoV2 burden in RD for 20-90 minutes after PI, HP or CHX in addition to the concurrently collected WMF. This is consistent with in vitro cell culture and RT-PCR studies that have shown reduction in SARS-CoV2 burden.2,3,5,6 We also demonstrated for the first time that RAT is superior to RT-PCR for determining the efficacy of interventions designed to decrease oral transmission. The unbiased detection of viral RNA by RT-PCR irrespective of active viral infection can be problematic. The detection of antigen using RAT or ELISA based technologies allows mitigation of non-infectious/non-viable RNA that may be detected by RT-PCR.

Data Availability

Data is not available in the links.

Funding

The study was funded by the intramural funds of Chennai Dental Research Foundation, Chennai, India.

References

  1. 1.↵
    Carrouel F, Goncalves LS, Conte MP, et al. Antiviral Activity of Reagents in Mouth Rinses against SARS-CoV-2. J Dent Res. 2020 Oct 22 : 0022034520967933.
  2. 2.↵
    Guenezan J, Garcia M, Strasters D, et al. Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. Published online February 04, 2021. doi:10.1001/jamaoto.2020.5490
    OpenUrlCrossRef
  3. 3.↵
    Kannian P, Lavanya C, Ravichandran K, et al. SARS-CoV2 antigen in whole mouth fluid may be a reliable rapid detection tool. Oral Dis 2021; doi: 10.1111/odi.13793.
    OpenUrlCrossRef
  4. 4.↵
    Lamas M, Dios PD, Rodriguez MTP et al. Is povidone iodine mouthwash effective against SARS-CoV-2? First in vivo tests. Oral Dis. 2020 Jul 2:10.1111/odi.13526. doi: 10.1111/odi.13526
    OpenUrlCrossRef
  5. 5.↵
    Seneviratne CJ, Balan P, Ki KKK et al. Efficacy of commercial mouthrinses on SARS-CoV-2 viral load in saliva: Randomized Controlled Trial in Singapore. MedRxiv 2020.09.14.20186494; doi:10.1101/2020.09.14.20186494
    OpenUrlAbstract/FREE Full Text
Back to top
PreviousNext
Posted March 01, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Povidone iodine, hydrogen peroxide and chlorhexidine mouthwashes reduce SARS-CoV2 burden in whole mouth fluid and respiratory droplets
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Povidone iodine, hydrogen peroxide and chlorhexidine mouthwashes reduce SARS-CoV2 burden in whole mouth fluid and respiratory droplets
Bagavad Gita Jayaraman, Gunaseelan Rajan, Priya Kannian, Chandra Lavanya, Krittika Ravichandran, Nagalingeswaran Kumarasamy, Kannan Ranganathan, Veeraraghavan Aswini, Pasuvaraj Mahanathi, Stephen Challacombe, Jennifer Webster-Cyriaque, Newell W Johnson
medRxiv 2021.02.25.21252488; doi: https://doi.org/10.1101/2021.02.25.21252488
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Povidone iodine, hydrogen peroxide and chlorhexidine mouthwashes reduce SARS-CoV2 burden in whole mouth fluid and respiratory droplets
Bagavad Gita Jayaraman, Gunaseelan Rajan, Priya Kannian, Chandra Lavanya, Krittika Ravichandran, Nagalingeswaran Kumarasamy, Kannan Ranganathan, Veeraraghavan Aswini, Pasuvaraj Mahanathi, Stephen Challacombe, Jennifer Webster-Cyriaque, Newell W Johnson
medRxiv 2021.02.25.21252488; doi: https://doi.org/10.1101/2021.02.25.21252488

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3296)
  • Dentistry and Oral Medicine (364)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13381)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5155)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3271)
  • Health Policy (1142)
  • Health Systems and Quality Improvement (1192)
  • Hematology (431)
  • HIV/AIDS (1018)
  • Infectious Diseases (except HIV/AIDS) (14632)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (524)
  • Neurology (4928)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (726)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4216)
  • Public and Global Health (7507)
  • Radiology and Imaging (1706)
  • Rehabilitation Medicine and Physical Therapy (1014)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)